The American Heart Association and ACC released the 2026 Guideline on Dyslipidemia management New guideline replaces old risk scores with the AHA PREVENT-ASCVD risk calculator for better risk assessment Statins remain first-line therapy for high-risk patients with new FDA-approved lipid-lowering options
